Hematologic Malignancies

2027 FASEB Science Research Conference

August 2-5, 2027
Niagara Falls Convention Center, Niagara Falls, NY #HEMSRC 
Registration coming in November

Conference Summary
The study of hematologic malignancies remains at the forefront of cancer research, providing unparalleled models for understanding the fundamental principles of stem-cell biology, clonal evolution, and genetic regulation. Unlike solid tumors, blood cancers have allowed scientists to track the stepwise accumulation of mutations from pre-malignant conditions like Clonal Hematopoiesis of Indeterminate Potential (CHIP) to overt leukemia, offering a transparent window into disease initiation. 

This conference will cover both myeloid and lymphoid-based malignancies; the integration of these lineage-specific topics is critical as it highlights shared mechanisms of oncogenesis, such as epigenetic remodeling, super-enhancer dysregulation, and the complex interplay between tumor cells and the immune microenvironment. 

This deep mechanistic focus is essential not only for mapping the distinct pathogenesis of B- and T-cell disorders versus myeloid neoplasms but also for understanding the broader physiological impacts of hematologic aging and immune evasion.

Attendees will learn about:

  • The development of next-generation therapeutics
  • The transition from broad cytotoxic treatments to precision medicine
  • The challenges of overcoming resistance mechanisms

Program topics include:

  • Targeting previously "undruggable" drivers
  • Bridging the gap between identifying molecular targets and deploying durable clinical cures
  • Connecting basic discovery and clinical application so that mechanistic insights into the development of malignant hematopoiesis rapidly translate into new therapeutics

Workshops:  

Meet the Experts session will be designed to bridge the gap between technical mastery and career development by hosting roundtables on navigating the transition from academia to industry, securing early-career funding from foundations (e.g., LLS, EHA, AACR), and understanding strategies for high-impact publishing.

The two Career Development Workshops will equip graduate students, post-doctoral fellows, and junior faculty with the essential skills and strategy necessary to navigate the transition to independence, with topics including discussing the use of AI and scientific publishing, demystifying the funding landscape for hematologic research and exploring diverse career trajectories beyond traditional academia.

Important Dates
Early Registration and Early Abstract Deadlines: June 7, 2027
Early abstracts may be considered for short talks or posters
Abstract Edit & Submission/Registration Cancellation Deadlines: July 13, 2027
Abstracts submitted after the early deadline will be considered for posters
Regular Registration Deadline: July 26, 2027 

Conference Venue
Sheraton Niagara Falls Hotel
300 3rd Street
Niagara Falls, New York, USA, 14303

The closest airports are:

Ross Levine, MD
Chief Scientific Officer and Edward P. Evans Endowed Chair for Myelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center
New York, New York

Jyoti Nangalia, MB BChir, PhD
Group Leader, Somatic Genomics Programme
Wellcome Sanger Institute
Hinxton, UK

Conference Organizers

Zuzanna Tothova, MD, PhD
Assistant Professor
Harvard Medical School
 Investigator
Dana-Farber Cancer Institute
 Associate Member
Broad Institute
Boston, MA

Grant Challen, PhD
Professor
Washington University Medical School

St. Louis, MO